|
ANKRA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.703200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.029000E-01 |
| Normal-vs-Stage2 |
9.703900E-02 |
| Normal-vs-Stage3 |
9.230200E-01 |
| Normal-vs-Stage4 |
8.456600E-01 |
| Stage1-vs-Stage2 |
1.645030E-01 |
| Stage1-vs-Stage3 |
6.147000E-01 |
| Stage1-vs-Stage4 |
9.146200E-01 |
| Stage2-vs-Stage3 |
1.318580E-01 |
| Stage2-vs-Stage4 |
2.950800E-01 |
| Stage3-vs-Stage4 |
8.243200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.342200E-01 |
| Normal-vs-AfricanAmerican |
4.198600E-01 |
| Normal-vs-Asian |
2.218400E-01 |
| Caucasian-vs-AfricanAmerican |
9.606400E-01 |
| Caucasian-vs-Asian |
5.312600E-01 |
| AfricanAmerican-vs-Asian |
5.684000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.875200E-01 |
| Normal-vs-Female |
6.521600E-02 |
| Male-vs-Female |
6.644500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.894600E-01 |
| Normal-vs-Extreme_Weight |
9.952400E-01 |
| Normal-vs-Obese |
2.122400E-01 |
| Normal-vs-Extreme_Obese |
6.457400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.159000E-01 |
| Normal_Weight-vs-Obese |
6.763600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.180400E-01 |
| Extreme_Weight-vs-Obese |
1.637440E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.913400E-01 |
| Obese-vs-Extreme_Obese |
2.862200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.393000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.245600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.443400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.943200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.104600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.799400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.798640E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.254000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.315570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.276600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.546000E-01 |
| Normal-VS-Type2 PRCC |
7.459400E-01 |
| Normal-VS-KIRP CIMP |
7.424000E-01 |
| Normal-VS-Unclassified PRCC |
1.392960E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.003800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.309000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.400200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.271000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.447600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.687800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.703600E-01 |
| Normal-vs-N1 |
5.670400E-01 |
| Normal-vs-N2 |
3.946600E-01 |
| N0-vs-N1 |
5.736800E-01 |
| N0-vs-N2 |
3.392400E-01 |
| N1-vs-N2 |
3.729200E-01 |
|
|
